MedTech Daily Briefing
2026-07-22
|
Section 1: MedTech Industry News
Philips wins FDA clearance for new pulse oximeter
MedTech Dive • July 21, 2026
|
Medtronic adds real-time AI to Hugo robot
MedTech Dive • July 21, 2026
|
GE HealthCare inks 10-year, $500M alliance with Catholic Health
MedTech Dive • July 21, 2026
|
Robotics developer Vicarious Surgical shuts down to liquidate assets - MassDevice
MassDevice • July 22, 2026
|
Hilo launches wearable blood pressure monitoring tech - MassDevice
MassDevice • July 21, 2026
|
Johnson & Johnson wins FDA nod for Ottava surgical robot - MassDevice
MassDevice • July 22, 2026
|
Smith+Nephew unveils expanded enterprise strategy for ASCs - MassDevice
MassDevice • July 21, 2026
|
BD president of Medical Essentials, BioPharma Systems to retire - MassDevice
MassDevice • July 22, 2026
|
Precision Neuroscience uses BCI to enable real-time thought-based control of computers - MassDevice
MassDevice • July 21, 2026
|
Ability Neurotech has first-in-human BCI procedure - MassDevice
MassDevice • July 21, 2026
|
Casana introduces smart toilet seat that measures blood pressure, heart rate - MassDevice
MassDevice • July 21, 2026
|
AiM Medical Robotics names new president, CFO - MassDevice
MassDevice • July 22, 2026
|
Science Corp. launches Prima vison-restoring BCI implant in Europe - MassDevice
MassDevice • July 22, 2026
|
Philips gets FDA nod for next-gen reusable pulse oximetry clip sensor - MassDevice
MassDevice • July 21, 2026
|
Medtronic to unveils AI computing platform for surgical robotics - MassDevice
MassDevice • July 21, 2026
|
Crystalys mines $130M series B to push gout drug through phase 3
Fierce Biotech • July 21, 2026
|
‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise
Fierce Biotech • July 21, 2026
|
‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx deal
Fierce Biotech • July 21, 2026
|
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
Fierce Biotech • July 21, 2026
|
Agios says adios to sickle cell program over lackluster phase 2 data
Fierce Biotech • July 21, 2026
|
Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’
Fierce Biotech • July 21, 2026
|
AI is moving inside the device. Who owns the clinical risk?
Medical Design & Outsourcing • July 21, 2026
|
Medtech CDMO Aptyx names new CEO
Medical Design & Outsourcing • July 21, 2026
|
How to Secure a Medical Device You Can’t Patch
Medical Design & Outsourcing • July 21, 2026
|
Inside the first-of-its-kind Enable Injections enFuse drug delivery wearable
Medical Design & Outsourcing • July 21, 2026
|
|
Section 2: National News — MedTech Relevant
|
Section 3: VC Press Releases
|
Section 4: Public Market Roundup — as of July 21, 2026
|
▲ Top Gainers
| CVRX |
CVRX |
+4.19% |
| CV |
CapsoVision |
+4.00% |
| HTFL |
Heartflow |
+3.58% |
|
|
▼ Top Losers
| KMTS |
Kestra |
-4.30% |
| ALC |
Alcon |
-3.84% |
| PRCT |
Procept |
-3.64% |
|
📅 Upcoming Earnings (Next 7 Days)
| EW |
Edwards Lifesciences |
July 23, 2026 |
| PHG |
Philips |
July 28, 2026 |
| BSX |
Boston Scientific |
July 29, 2026 |
| GEHC |
GE HealthCare |
July 29, 2026 |
| IART |
Integra LifeSciences |
July 29, 2026 |
| ALGN |
Align Technology |
July 29, 2026 |
| AXGN |
Axogen |
July 29, 2026 |
| BBNX |
Beta Bionics |
July 29, 2026 |
| GKOS |
Glaukos |
July 29, 2026 |
|
|
MedTech Daily Briefing • Curated by automation
|
|